MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) today announced the appointment of Dan Brennan and Mark Vergnano, to its Board of Directors, effective November 23, 2022. Mr. Brennan currently serves as Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical device company, and Mr. Vergnano is the former Chairman, President and Chief Executive Officer of The Chemours Company, a chemistry company. “Dan and Mark are outstanding leaders

The top-notch information research report published by ReportsnReports is a vital asset that offers qualitative and quantitative factors of the Microelectronic Medical Implants market. The research study and methodologies mentioned in the report examine the critical vendors by considering their

NORTHAMPTON, MA / ACCESSWIRE / November 18, 2022 / Climate change. Environmental protection. Hiring inequities. Economic disparities. Over the past few years, Environmental, Social and Governance (ESG)-or the priorities a company shares publicly for how it operates its business and cares for the world around it-has increasingly become an area of focus for Boston Scientific. To that end, the company recently appointed Kathryn Unger to the newly created role of vice president of ESG. And while this is her first ESG-related job, it''s one that she''s personally passionate about and for which Unger is uniquely qualified: From her first job as a high school teacher to a more recent role leading a large, highly regulated business, she''s a seasoned executive with deep, diverse experiences to draw from. We sat down with her to find out more about how she defines ESG, how Boston Scientific is leading its peers when it comes to its environmental goals and why this work is so crucial for the sake of the planet as well as the patients, customers and employees Boston Scientific serves.

NORTHAMPTON, MA / ACCESSWIRE / November 11, 2022 / Our commitment to advancing diversity, equity and inclusion in the workplace has been recognized by Seramount, part of EAB ''s 2022 Inclusion Index! Read more about our best practices: https://bit.ly/3G2szZh View original content here . About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook . View additional multimedia and more ESG storytelling from Boston Scientific on 3blmedia.com. Contact Info: Spokesperson: Boston Scientific Website: https://www.bostonscientific.com/en-US/Home.html Email: info@3blmedia.com SOURCE: Boston Scientific

Boston Scientific stock is up 6% in a month, marginally outperforming the broader S&P500 index, up 4%. The company reported its Q3 results in late October. Its top line was in…

The Pancreatic And Biliary Stents Market is likely to grow at an impertinent level shortly. Chabot''s powered by machine learning is the transformation of the way interaction amongst patients happens. Machine learning is there to help radiologists to identify differences

Boston Scientific Corporation (NYSE:BSX) has a beta value of 0.83 and has seen 7.74 million shares traded in the last trading session. The company, currently valued at $58.98B, closed the last trade at $42.76 per share which meant it lost -$0.35 on the day or -0.81% during that session. The BSX stock price is -11.06% … Boston Scientific Corporation (BSX) Is A Buy Stock For Small Caps – Analysts Read More »

NEW YORK, Oct. 28, 2022 /PRNewswire/ -- The fiducial markers market size is expected to grow by USD 36.5 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.66% during the forecast period, according to Technavio. The rising global…

Digital Gastrointestinal Machine is a hi-tech medical invention that can help alleviate the symptoms of gastrointestinal disorders. It has been designed by a team of engineers who were determined to help individuals who are suffering from irregularity, indigestion and bloating. Digital

https://www.investing.com/news/pro/boston-scientific-pt-raised-to-47-at-evercore-isi-432SI-2922578

NORTHAMPTON, MA / ACCESSWIRE / October 26, 2022 / Boston Scientific At Boston Scientific, our people are at the core of what we do - and our appreciation for them is reflected in our wide range of employee benefits. Wherever you are in life, we meet you with the physical, emotional, and financial support you need and make it easy to find those resources. Our "whole person" approach is one of the many reasons we''re consistently hailed among the Best Places to Work by outlets including Glassdoor, Seramount, Forbes , Newsweek and Fast Company . Your Boston Scientific benefits may vary based on where in the world you join us. But here''s a small sampling of a dozen of our U.S. employee benefits. 1. Family-Planning Support Our partnership with Maven offers comprehensive care for those planning, expecting and starting a family. Available at no cost to employees and partners who are pursuing fertility treatment, pregnant or up to 6 months postpartum, Maven provides unlimited on-demand virtual appointments with providers; referrals to top specialists in your area; community spaces to find support; and a dedicated care advocate to help you navigate it all.

Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Presentation: Operator Good morning, and welcome to the Boston Scientific Third Quarter 2022 Earnings Call. [Operator Instructions] […] The post Boston Scientific Corp. (BSX) Q3 2022 Earnings Call Transcript first appeared on AlphaStreet .

Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Presentation: Operator Good morning, and welcome to the Boston Scientific Third Quarter 2022 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Lauren Tengler, Vice President, Investor Relations. Please go […]

WASHINGTON (dpa-AFX) - Medical devices maker Boston Scientific Corporation (BSX) Wednesday reported lower profit in the third quarter despite growth in revenue. The company also reduced its full-y…

Boston Scientific (BSX) dropped ~4% pre-market Wednesday after the health equipment maker reported Q3 2022 results and set a lower-than-expected guidance for the current quarter and…

Boston Scientific Misses Q3 EPS by 1c

Boston Scientific Earnings Miss, Revenue Beats In Q3

Boston Scientific press release (BSX): Q3 Non-GAAP EPS of $0.43 misses by $0.01.Revenue of $3.17B (+8.2% Y/Y) beats by $30M.MedSurg: 6.5 percent reported, 11.0 percent operational…

Boston Scientific (BSX) is scheduled to announce Q3 earnings results on Wednesday, October 26th, before market open

Not only do we expect Boston Scientific to navigate well in Q3, our forecast indicates that BSX stock has ample room for growth, as discussed below.

https://www.investing.com/news/pro/boston-scientific-added-to-the-analyst-current-favorites-list-at-raymond-james-432SI-2919694

Boston Scientific is one of the best-performing stocks in the industry YTD and has an earnings report Wednesday morning. Check out why I''m bullish on BSX stock.

The top-notch information research report published by ReportsnReports is a vital asset that offers qualitative and quantitative factors of the Congenital Heart Defect Closure Devices market. The research study and methodologies mentioned in the report examine the critical vendors by

Boston Scientific Corporation found using ticker (BSX) now have 22 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 53 and 43 calculating the mean target price we have 48.49. With the stocks previous close at 40.65 this now indicates there is a potential upside of 19.3%. There is a 50 day moving average of 40.99 and the 200 moving average now moves to 41.4. The market capitalisation for the company is $56,921m. Company Website: https://www.bostonscientific.com [stock_market_widget type="chart" template="basic" color="green" assets="BSX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $67,899m based on the market concensus. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.

The following slide deck was published by Boston Scientific Corporation in conjunction with this event.

The global "Electro-Diagnostic Devices Market" report aims to provide a detailed analysis of the factors that influence the global business adoption and segmentation outlook. The detailed information and overview of the global Electro-Diagnostic Devices market report highlight the latest development

The trading price of Boston Scientific Corporation (NYSE:BSX) floating higher at last check on Monday, October 03, closing at $39.88, 2.97% higher than its previous close. Traders who pay close attention to intraday price movement should know that it has been fluctuating between $38.70 and $39.99. The company’s P/E ratio in the trailing 12-month period … Boston Scientific Corporation (NYSE: BSX) Stock Forecast: Potential To Pass $53.00 Within A Year Read More »

NORTHAMPTON, MA / ACCESSWIRE / October 3, 2022 / Truveta announced a strategic collaborative agreement with Boston Scientific Corporation whereby Boston Scientific researchers will be able to access data from Truveta that contains deidentified medical records from more than 65 million patients in the United States. According to Truveta, the collaboration seeks to improve long-term patient care and gain insights into health care disparities. Continue reading here. View additional multimedia and more ESG storytelling from Boston Scientific on 3blmedia.com. Contact Info: Spokesperson: Boston Scientific Website: https://www.bostonscientific.com/en-US/Home.html Email: info@3blmedia.com SOURCE: Boston Scientific

MARLBOROUGH, Mass., Oct. 3, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2022 on Wednesday, October 26, 2022 at 8:00 a.m. EDT. The call will be…

Boston Scientific (BSX) has entered into a collaboration with Truveta, which provides de-identified health data, to analyze patient outcomes related to use of the device companys products.

Seattle-area health data startup Truveta announced a collaboration Tuesday with Boston Scientific, a leading medical device company. The partnership will enable Boston Scientific researchers to access Truveta’s de-identified data from… Read More

Truveta Health System Membership Truveta is a collective of U.S. health systems with a shared vision of saving lives with data. Truveta’s 24 members provide patient care in over 20,000 clinics and 700 hospitals across 43 states. De-identified data from this care is provided to Truveta daily. BELLEVUE, Wash., Sept. 27, 2022 (GLOBE NEWSWIRE) — … The post Truveta Announces Collaboration with Boston Scientific to Advance Post-Procedure Patient Insights and Help Address Healthcare Disparities appeared first on ForexTV .